672 related articles for article (PubMed ID: 30242519)
1. Migraine and cluster headache - the common link.
Vollesen AL; Benemei S; Cortese F; Labastida-Ramírez A; Marchese F; Pellesi L; Romoli M; Ashina M; Lampl C;
J Headache Pain; 2018 Sep; 19(1):89. PubMed ID: 30242519
[TBL] [Abstract][Full Text] [Related]
2. The role of anti-CGRP antibodies in the pathophysiology of primary headaches.
Barbanti P; Aurilia C; Fofi L; Egeo G; Ferroni P
Neurol Sci; 2017 May; 38(Suppl 1):31-35. PubMed ID: 28527063
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment.
Ashina H; Newman L; Ashina S
Neurol Sci; 2017 Dec; 38(12):2089-2093. PubMed ID: 28856479
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review.
Tfelt-Hansen P; Le H
J Headache Pain; 2009 Jun; 10(3):137-43. PubMed ID: 19330286
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiological role of calcitonin gene-related peptide (CGRP) in migraine and cluster headache].
Meßlinger K
Schmerz; 2020 Apr; 34(2):181-187. PubMed ID: 32103345
[TBL] [Abstract][Full Text] [Related]
6. CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data.
Khan S; Olesen A; Ashina M
Cephalalgia; 2019 Mar; 39(3):374-389. PubMed ID: 29110503
[TBL] [Abstract][Full Text] [Related]
7. Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series.
Iannone LF; Fattori D; Geppetti P; De Cesaris F
Neurol Sci; 2022 Jan; 43(1):697-703. PubMed ID: 34586542
[TBL] [Abstract][Full Text] [Related]
8. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
Yuan H; Spare NM; Silberstein SD
Headache; 2019 Jul; 59 Suppl 2():20-32. PubMed ID: 31291020
[TBL] [Abstract][Full Text] [Related]
9. Triptans and CGRP blockade - impact on the cranial vasculature.
Benemei S; Cortese F; Labastida-Ramírez A; Marchese F; Pellesi L; Romoli M; Vollesen AL; Lampl C; Ashina M;
J Headache Pain; 2017 Oct; 18(1):103. PubMed ID: 29019093
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review.
Schuster NM; Rapoport AM
Clin Neuropharmacol; 2017; 40(4):169-174. PubMed ID: 28644160
[TBL] [Abstract][Full Text] [Related]
11. Some aspects on the pathophysiology of migraine and a review of device therapies for migraine and cluster headache.
Rapoport AM; Edvinsson L
Neurol Sci; 2019 May; 40(Suppl 1):75-80. PubMed ID: 30906962
[TBL] [Abstract][Full Text] [Related]
12. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack.
Fanciullacci M; Alessandri M; Figini M; Geppetti P; Michelacci S
Pain; 1995 Feb; 60(2):119-123. PubMed ID: 7540279
[TBL] [Abstract][Full Text] [Related]
13. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Knight YE; Edvinsson L; Goadsby PJ
Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
[TBL] [Abstract][Full Text] [Related]
14. Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients.
Fanciullacci M; Alessandri M; Sicuteri R; Marabini S
Brain; 1997 Feb; 120 ( Pt 2)():283-8. PubMed ID: 9117375
[TBL] [Abstract][Full Text] [Related]
15. Galcanezumab: a humanized monoclonal antibody for the prevention of migraine and cluster headache.
Ossipov MH; Raffa RB; Pergolizzi JV
Drugs Today (Barc); 2020 Jan; 56(1):5-19. PubMed ID: 32055802
[TBL] [Abstract][Full Text] [Related]
16. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
17. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
Edvinsson L
Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
[TBL] [Abstract][Full Text] [Related]
18. Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors.
Melo-Carrillo A; Strassman AM; Nir RR; Schain AJ; Noseda R; Stratton J; Burstein R
J Neurosci; 2017 Nov; 37(44):10587-10596. PubMed ID: 28972120
[TBL] [Abstract][Full Text] [Related]
19. Debate: Are cluster headache and migraine distinct headache disorders?
Al-Karagholi MA; Peng KP; Petersen AS; De Boer I; Terwindt GM; Ashina M
J Headache Pain; 2022 Nov; 23(1):151. PubMed ID: 36447146
[TBL] [Abstract][Full Text] [Related]
20. Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster Headache.
Halker Singh RB; Ailani J; Robbins MS
Headache; 2019 Jul; 59 Suppl 2():33-49. PubMed ID: 31291017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]